Clinical Trial Update: Comparison of Prasugrel and Ticagrelor in the Treatment of Acute Myocardial Infarction [Phase 4]

View source ↗

Summary

A Phase 4 study comparing prasugrel and ticagrelor in acute myocardial infarction has completed. It provides head-to-head data on two antiplatelet therapies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• BRILINTA (ticagrelor)
• EFFIENT (prasugrel hydrochloride)

Snippet

Sponsor: Faculty Hospital Kralovske Vinohrady | Conditions: Myocardial Infarction, Angioplasty, Balloon, Coronary | Phase 4 | Status: COMPLETED